Imagerie Moléculaire et Stratégies Théranostiques
Impact in
-
- Breast Cancer Treatment Studies
-
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 54
- HER2/EGFR in Cancer Research 12
- Cancer Immunotherapy and Biomarkers 11
-
- Breast Cancer Treatment Studies 21
- Top scholars
- Frederique Madeleine Penault-LlorcaFátima CardosoPhilip M. PoortmansElżbieta SenkusShinji OhnoSophia ZackrissonStella KyriakidesIsabel Teresa Rubio
- Journals
- Cancers (15 papers)Frontiers in Oncology (11 papers)BMC Cancer (9 papers)OMICS A Journal of Integrative Biology (7 papers)Oncotarget (6 papers)
- Partner nations
- FranceGermanyUnited States
In The Last Decade
Imagerie Moléculaire et Stratégies Théranostiques
321 papers receiving 7.4k citations
Peers
Comparison fields: 5 of 144
- Cancer Research 1.6k
- Oncology 1.6k
- Radiology, Nuclear Medicine and Imaging 700
- Pulmonary and Respiratory Medicine 683
- Genetics 153
Countries citing scholars working at Imagerie Moléculaire et Stratégies Théranostiques
This map shows the geographic impact of research produced by authors working at Imagerie Moléculaire et Stratégies Théranostiques. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Imagerie Moléculaire et Stratégies Théranostiques with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Imagerie Moléculaire et Stratégies Théranostiques more than expected).
Fields of papers published by authors at Imagerie Moléculaire et Stratégies Théranostiques
This network shows the impact of papers affiliated with Imagerie Moléculaire et Stratégies Théranostiques at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Imagerie Moléculaire et Stratégies Théranostiques at the time of their publication.
About Imagerie Moléculaire et Stratégies Théranostiques
In recent decades, authors affiliated with Imagerie Moléculaire et Stratégies Théranostiques have published 344 papers, which have received a total of 7.5k indexed citations . Scholars at this organization have produced 54 papers in Oncology, 30 papers in Cancer Research, 43 papers in Radiology, Nuclear Medicine and Imaging, 10 papers in Otorhinolaryngology and 19 papers in Rheumatology on the topics of Radiopharmaceutical Chemistry and Applications (25 papers), Breast Cancer Treatment Studies (21 papers), Epigenetics and DNA Methylation (16 papers), HER2/EGFR in Cancer Research (12 papers), Glioma Diagnosis and Treatment (12 papers), Cancer Immunotherapy and Biomarkers (11 papers), Prostate Cancer Treatment and Research (10 papers) and Reproductive Biology and Fertility (10 papers). Their work is cited by papers focused on Cancer Research (1.6k citations), Oncology (1.6k citations), Radiology, Nuclear Medicine and Imaging (700 citations), Pulmonary and Respiratory Medicine (683 citations) and Genetics (153 citations). Authors at Imagerie Moléculaire et Stratégies Théranostiques collaborate with scholars in France, Germany and United States and have published in prestigious journals including Cancers, Frontiers in Oncology, BMC Cancer, OMICS A Journal of Integrative Biology and Oncotarget. Some of Imagerie Moléculaire et Stratégies Théranostiques's most productive authors include Frederique Madeleine Penault-Llorca, Fátima Cardoso, Philip M. Poortmans, Elżbieta Senkus, Shinji Ohno, Sophia Zackrisson, Stella Kyriakides, Isabel Teresa Rubio, Emmanuel Moreau and Françoise Degoul.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.